Publications

2024

  1. Juutinen, L, Ahinko, K, Hagman, S, Basnyat, P, Jääskeläinen, O, Herukka, SK et al.. The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis. Mult Scler Relat Disord. 2024;85 :105517. doi: 10.1016/j.msard.2024.105517. PubMed PMID:38442501 .

Search PubMed

2022

  1. Vistbakka, J, Sumelahti, ML, Lehtimäki, T, Hagman, S. Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up study. J Neurol Sci. 2022;442 :120395. doi: 10.1016/j.jns.2022.120395. PubMed PMID:36084364 .
  2. Lotila, J, Hyvärinen, T, Skottman, H, Airas, L, Narkilahti, S, Hagman, S et al.. Establishment of a human induced pluripotent stem cell line (TAUi008-A) derived from a multiple sclerosis patient. Stem Cell Res. 2022;63 :102865. doi: 10.1016/j.scr.2022.102865. PubMed PMID:35843021 .
  3. Mzezewa, R, Lotila, J, Kiiski, H, Vinogradov, A, Kapucu, FE, Peltola, J et al.. A kainic acid-induced seizure model in human pluripotent stem cell-derived cortical neurons for studying the role of IL-6 in the functional activity. Stem Cell Res. 2022;60 :102665. doi: 10.1016/j.scr.2022.102665. PubMed PMID:35091307 .

Search PubMed

2021

Mervi Ristola, Chiara Fedele, Sanna Hagman, Lassi Sukki, Emre Kapucu, Ropafadzo Mzezewa, Tanja Hyvärinen, Pasi Kallio, Arri Priimägi, Susanna Narkilahti. Directional Growth of Human Neuronal Axons in a Microfluidic Device with Nanotopography on Azobenzene-Based Material. Advanced Biomaterial Interfaces 2021 DOI: 10.1002/admi.202100048 (Open access))

2020

  1. Juntunen, M, Hagman, S, Moisan, A, Narkilahti, S, Miettinen, S. Oxygen-Glucose Deprivation-Induced Stroke Models with Human Neuroblastoma Cell- and Induced Pluripotent Stem Cell-Derived Neurons. Stem Cells Int. 2020;2020 :8841026. doi: 10.1155/2020/8841026. PubMed PMID:33178286 PubMed Central PMC7647751.

Search PubMed

2019

  1. Hyvärinen, T, Hagman, S, Ristola, M, Sukki, L, Veijula, K, Kreutzer, J et al.. Co-stimulation with IL-1β and TNF-α induces an inflammatory reactive astrocyte phenotype with neurosupportive characteristics in a human pluripotent stem cell model system. Sci Rep. 2019;9 (1):16944. doi: 10.1038/s41598-019-53414-9. PubMed PMID:31729450 PubMed Central PMC6858358.
  2. Basnyat, P, Sumelahti, ML, Lehtimäki, T, Elovaara, I, Hagman, S. Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis. J Neuroimmunol. 2019;335 :577020. doi: 10.1016/j.jneuroim.2019.577020. PubMed PMID:31445379 .
  3. Kolasa, M, Hakulinen, U, Brander, A, Hagman, S, Dastidar, P, Elovaara, I et al.. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study. Brain Behav. 2019;9 (1):e01194. doi: 10.1002/brb3.1194. PubMed PMID:30588771 PubMed Central PMC6346728.
  4. Hagman, S, Mäkinen, A, Ylä-Outinen, L, Huhtala, H, Elovaara, I, Narkilahti, S et al.. Effects of inflammatory cytokines IFN-γ, TNF-α and IL-6 on the viability and functionality of human pluripotent stem cell-derived neural cells. J Neuroimmunol. 2019;331 :36-45. doi: 10.1016/j.jneuroim.2018.07.010. PubMed PMID:30195439 .

Search PubMed